Case Studies

Case_Study_Addenbrooks_2011
Date: 01 Oct 2011

View case study

Case_Study_Papworth_2011
Date: 01 Oct 2011

View case study

Case_Study_Sheffield_2011
Date: 01 Oct 2011

View case study

Abstract_Forced_Expiratory_Volumes_ATS_2009
Date: 01 Dec 2009

View case study

Abstract_Forced_Expiratory_Volumes_BTS_2009
Date: 01 Dec 2009

View case study

Abstract_Tidal_Breathing_BTS_2009
Date: 01 Dec 2009

View case study

McKinley
Date: 01 Jul 2007

• McKinley was part of Broe Companies Inc
• Sage engaged with McKinley Medical's management to sell its Walkmed drug infusion business as part of a corporate divestiture program
• WalkMed Infusion LLC was...

  View case study

Microdose Technologies

• Sage invested over $200,000 in MicroDose at $1 per share as part of a financing in excess of $750,000 arranged by Sage.
• Sage assisted in negotiating a $30 million marketing partnership with BMS for a joint ventur...

  View case study

Biotrin

• Requested by Board and VC investors to engineer an exit route from this Dublin-based clinical diagnostics company
• Assisted company to increase US-based market share
• Developed IM and identified sever...

  View case study

Cytomyx

• Biotech drug discovery company quoted on AIM market of the London Stock Exchange
• Board sought to divest company to realize cash return in light of depressed market capitalisation
• Sage identified Ser...

  View case study

Noven

• Noven, a specialty neuro pharma company, engaged Sage to assist it in a buyside transaction
• Objectives were specified as increasing revenue, requirement for an expanded sales infrastructure and enhanced product p...

  View case study

Life Science Resources

• Assisted in founding of company involved in photonics and biological imaging for high throughput drug discovery and proteomics
• Assisted in fund raising and technology/IP development
• Developed high p...

  View case study

NatImmune

• Tired investors desiring a partnership of the lead protein replacement technology before further supporting the company
• Sage engaged Enzon as well as three other parties
• Closed a deal with $10 mil. ...

  View case study

RGene Therapeutics

• Sage assisted in negotiating a $1 million patent license with Pasteur Merieux Connaught
• Sage assisted in negotiating a $30 million European marketing partnership with Fournier
• As a result of these t...

  View case study

SK BioPharmaceuticals

• Small US biopharm subsidiary of SK Corporation of Korea seeking to out-license an anti-epileptic and anti-depressant in early clinical trials
• Little or no experience with multi-national pharma
• Sage ...

  View case study

Luminex

• Sage worked with this imaging/diagnostics company from a startup with 3 employees in a garage
• Sage wrote the company’s first business plan and investment memorandum for a novel diagnostics business
...

View case study

Focal

• Engaged with the company to advise on marketing and regulatory hurdles to develop polymer bioadhesive medical technology as a lung sealant
• Prepared a detailed valuation model which led to business plan and inform...

  View case study

NitroMed

• Sold non-relevant patent right Ohmeda for $1 million within 90 days of getting assignment
• Internal investors heartened to bridge additional funds
• Completed two licensing transactions with J&J co...

  View case study

Cenix

• Engaged with RNAi biotech company at invitation of principal shareholders
• Developed IM and divestment strategy to realise exit for investors
• Divested primary technology platform to Ambion, who were ...

  View case study

iStat Corporation

• Served as first President and CEO
• Developed chemical biosensors in the medical technology space for blood gases and analytes
• Developed commercialisation and funding strategies for the company over s...

  View case study